Ampio Pharmaceuticals (AMPE)

$0.00 +0.00 (3.57%)
Market Cap 3,000.00
Revenue (ttm) 0.00
Net Income (ttm) -8.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 300
Avg Vol 1,032
Day's Range N/A - N/A
Shares Out 1.14M
Stochastic %K 28%
Beta 4.76
Analysts Strong Buy
Price Target $44.98

Company Profile

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.

Industry: Biotechnology
Sector: Healthcare
Phone: 720 437 6500
Address:
9800 Mount Pyramid Court, Suite 400, Englewood, United States
11thestate
11thestate Jul. 22 at 1:29 PM
$AMPE losses? There is a recovery path you can follow. Here’s where to start: https://11th.com/cases/ampio-shareholder-settlement #Ampio #AMPE
0 · Reply
11thestate
11thestate Jul. 11 at 5:49 AM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented the efficacy of its drug Ampion. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.02 per share — but if only 25% of eligible investors file, the payout could increase to $0.08 per share. Can I still file? Yes — late claims are currently being considered, subject to court approval. When do payouts happen? Typically 8–12 months after the court grants final approval (hearing set for February 19, 2025). To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Jul. 2 at 10:59 AM
#Ampio has agreed to a $3M settlement with $AMPE investors to resolve claims it misrepresented the effectiveness of Ampion for treating inflammatory conditions. If you bought $AMPE between December 29, 2020, and October 31, 2022, you can file a claim for payment here: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Jun. 24 at 10:28 AM
$AMPE investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #Ampio $AMPE https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Jun. 12 at 10:47 PM
Don’t forget that if you held $AMPE, there’s a significant settlement you can also claim. Consider it the dividend #Ampio never paid. https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
MrVenndram
MrVenndram Jun. 7 at 12:25 PM
$AMPE 4,000% What is latest on assets, intellectual property etc?
1 · Reply
11thestate
11thestate Jun. 4 at 12:13 PM
Don’t forget that if you held $AMPE, there’s a significant settlement you can also claim. Consider it the dividend #Ampio never paid. https://11th.com/cases/ampio-shareholder-settlement
1 · Reply
11thestate
11thestate May. 30 at 1:18 PM
$AMPE stockholders filed a claim against Ampio for allegedly withholding negative trial results and misrepresenting the efficacy of its AP-013 clinical study. You can join this case to be notified about any new information: https://11th.com/cases/ampio-inactive-investigation
0 · Reply
Optiongenius
Optiongenius May. 27 at 11:40 PM
$AMPE WHERES TOPQUEER 😂
1 · Reply
11thestate
11thestate May. 23 at 11:23 PM
$AMPE investors, if you follow us, you already knew about it. This is the good news you needed about $AMPE today. Go check it out. #AmpioPharmaceuticals #AMPE https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
Latest News on AMPE
No data available.
11thestate
11thestate Jul. 22 at 1:29 PM
$AMPE losses? There is a recovery path you can follow. Here’s where to start: https://11th.com/cases/ampio-shareholder-settlement #Ampio #AMPE
0 · Reply
11thestate
11thestate Jul. 11 at 5:49 AM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented the efficacy of its drug Ampion. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.02 per share — but if only 25% of eligible investors file, the payout could increase to $0.08 per share. Can I still file? Yes — late claims are currently being considered, subject to court approval. When do payouts happen? Typically 8–12 months after the court grants final approval (hearing set for February 19, 2025). To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Jul. 2 at 10:59 AM
#Ampio has agreed to a $3M settlement with $AMPE investors to resolve claims it misrepresented the effectiveness of Ampion for treating inflammatory conditions. If you bought $AMPE between December 29, 2020, and October 31, 2022, you can file a claim for payment here: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Jun. 24 at 10:28 AM
$AMPE investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #Ampio $AMPE https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Jun. 12 at 10:47 PM
Don’t forget that if you held $AMPE, there’s a significant settlement you can also claim. Consider it the dividend #Ampio never paid. https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
MrVenndram
MrVenndram Jun. 7 at 12:25 PM
$AMPE 4,000% What is latest on assets, intellectual property etc?
1 · Reply
11thestate
11thestate Jun. 4 at 12:13 PM
Don’t forget that if you held $AMPE, there’s a significant settlement you can also claim. Consider it the dividend #Ampio never paid. https://11th.com/cases/ampio-shareholder-settlement
1 · Reply
11thestate
11thestate May. 30 at 1:18 PM
$AMPE stockholders filed a claim against Ampio for allegedly withholding negative trial results and misrepresenting the efficacy of its AP-013 clinical study. You can join this case to be notified about any new information: https://11th.com/cases/ampio-inactive-investigation
0 · Reply
Optiongenius
Optiongenius May. 27 at 11:40 PM
$AMPE WHERES TOPQUEER 😂
1 · Reply
11thestate
11thestate May. 23 at 11:23 PM
$AMPE investors, if you follow us, you already knew about it. This is the good news you needed about $AMPE today. Go check it out. #AmpioPharmaceuticals #AMPE https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 16 at 12:20 PM
$AMPE agreed to a $3M settlement with investors over claims it misled them about the efficacy of its drug Ampion. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.15 per share — but if only 25% of eligible investors file, it could go up to $0.60 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 16 at 11:49 AM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented the efficacy of Ampion in treating inflammatory conditions. Who’s eligible? Anyone who bought and held $AMPE stock between October 31, 2022 and January 13, 2025. Do I need to sell to qualify? No — you're eligible if you bought during that period, even if you still hold the shares. How much is the payout? Estimated at $0.15 per share — but if only 25% of eligible investors file, it could go up to $0.60 per share. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Usually 8–12 months after the court grants final approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
1 · Reply
11thestate
11thestate May. 15 at 12:07 PM
$AMPE stockholders filed a claim against Ampio Pharmaceuticals for misleading them about the efficacy results and disclosures related to its AP-013 clinical trial. You can join this case to be notified about potential recovery: https://11th.com/cases/ampio-inactive-investigation
0 · Reply
11thestate
11thestate May. 9 at 12:11 PM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented Ampion’s effectiveness in treating inflammatory conditions. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.15 per share, depending on how many investors file. Can I still file? Yes — late claims are currently being accepted, subject to court approval. When do payouts happen? Usually 8–12 months after final approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate May. 2 at 12:12 PM
$AMPE agreed to a $3M settlement with investors over claims it misled the public about the effectiveness of its drug Ampion. Who’s eligible? Anyone who bought $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.15 per share, but if only 25% of eligible investors file, it could go up to $0.60 per share. Can I still file? Yes — late claims are currently being accepted, subject to court approval. When do payouts happen? Usually 8–12 months after the final approval hearing on February 19, 2025. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
1 · Reply
11thestate
11thestate Apr. 25 at 11:57 AM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented the efficacy of its Ampion drug. Who’s eligible? Anyone who purchased or otherwise acquired Ampio ($AMPE) common stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you’re eligible even if you still hold the shares, as long as you bought during the class period. How much is the payout? Estimated at $0.15 per share, depending on the number of valid claims submitted. Can I still file? Yes — late claims are being accepted, subject to court approval. When will payments go out? Payouts usually happen 8–12 months after the final approval hearing. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Apr. 21 at 12:56 AM
$AMPE agreed to a $3M settlement with investors over claims it misrepresented the effectiveness of its drug Ampion in treating inflammatory conditions. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold later. How much is the payout? Estimated at $0.15 per share, depending on how many valid claims are filed. Can I still file? Yes — late claims are currently being accepted. When do payouts happen? Typically 8–12 months after final court approval. To file your claim: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Apr. 11 at 12:04 PM
$AMPE agreed to a $3M settlement with investors to end claims that it misrepresented Ampion's efficacy in treating individuals with inflammatory conditions. Even if the deadline has passed, if you bought $AMPE between December 29, 2020, and August 02, 2022, you can file for payment here: https://11th.com/cases/ampio-shareholder-settlement
2 · Reply
11thestate
11thestate Apr. 4 at 10:23 AM
$AMPE agreed to a $3M settlement with investors to end claims that it misrepresented Ampion's efficacy in treating individuals with inflammatory conditions. Even if the deadline has passed, if you bought $AMPE between December 29, 2020, and August 02, 2022, you can file for payment here: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 30 at 12:25 PM
$AMPE Rough road for AMPE. OA-201 might be their last shot, but legal drama and cash burn are major red flags. Watching closely but skeptical. Not touching until more clarity emerges. compelling article: https://beyondspx.com/article/ampio-pharmaceuticals-ampe-a-tumultuous-journey-marked-by-setbacks-and-regulatory-challenges
0 · Reply
11thestate
11thestate Mar. 28 at 11:17 AM
$AMPE agreed to a $3M settlement with investors to end claims that it misrepresented Ampion's efficacy in treating individuals with inflammatory conditions. Even if the deadline has passed, if you bought $AMPE between December 29, 2020, and August 02, 2022, you can file for payment here: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply
11thestate
11thestate Mar. 21 at 12:03 PM
$AMPE agreed to a $3M settlement with investors to end claims that it misrepresented Ampion's efficacy in treating individuals with inflammatory conditions. Even if the deadline has passed, if you bought $AMPE between December 29, 2020, and August 02, 2022, you can file for payment here: https://11th.com/cases/ampio-shareholder-settlement
0 · Reply